Jan 172018

Multiple randomized trials have suggested that vitamin D supplementation might improve asthma control and reduce severity of asthma attacks. A new meta-analysis bolsters that hypothesis, and may encourage more physicians and people with asthma to consider vitamin D supplements for low vitamin D levels.

In a study in Lancet Respiratory Medicine, authors analyzed the experience of 955 asthma patients previously enrolled in seven randomized controlled trials testing vitamin D versus placebo.

Supplementation with vitamin D was associated with a 50% reduction in asthma attacks severe enough to require hospitalization or emergency department visit (3% vs 6%), compared to placebo. Vitamin D use was also associated with a 30% reduction in asthma attacks necessitating use of systemic corticosteroids.

Importantly, patients with low baseline vitamin D levels (<25 nmol/L serum 25(OH)D ) experienced statistically significant benefits, while those with higher baseline levels did not--suggesting vitamin D supplementation might be more beneficial in patients with asthma and low baseline vitamin D levels.

The treatment effect was strong enough to be seen in the overall cohort, with an adjusted incidence ratio of 0.74 for a severe asthma exacerbation among patients taking vitamin D (irrespective of baseline vitamin D level).

The study echoes a previous finding in a 2016 Cochrane meta-analysis that concluded supplementing vitamin D resulted in a 37% reduction in asthma exacerbations requiring systemic corticosteroids. That analysis could not stratify patients by baseline vitamin D levels, however.

The meta-analysis was underpowered to definitively conclude that patients with lower vitamin D levels experienced a reduction in asthma exacerbation severity. Editorialists called for a large, adequately powered randomized trial to answer the question:

Certainly there is a case to answer and definitive well powered randomized placebo controlled trials need to be done as a priority because the magnitude of the reduction in risk of severe exacerbations with vitamin D reported in this meta-analysis is substantial.

Given the relative benignity of vitamin D supplementation, and the magnitude of a potential benefit, the analysis will likely lead many physicians to test vitamin D levels in patients with a history of severe asthma exacerbations, and to advise supplementation in patients with low levels.

Sources: Lancet Resp Med, Cochrane Reviews

Get our weekly email update, and explore our library of practice updates and review articles.

PulmCCM is an independent publication not affiliated with or endorsed by any organization, society or journal referenced on the website. (Terms of Use | Privacy Policy)


Vitamin D improved asthma symptoms and reduced exacerbations